Harold Smith, PhD is a cell and molecular biologist and full professor in the Department of Biochemistry and Biophysics at the University of Rochester, School of Medicine and Dentistry.
Dr. Smith is the founder and CEO of Oyagen, a Rochester-based biotech company that recently announced their discovery of OYA-1, a promising new antiviral treatment to COVID-19.
We discuss the promising role that Cannabis could play in the management and treatment COVID-19.
Resource: https://www.projectcbd.org/medicine/cannabis-cbd-covid-19
** Inquiries: Harold_Smith@urmc.rochester.edu
Information
- Show
- PublishedApril 2, 2020 at 10:00 AM UTC
- Length53 min
- RatingClean